(R)-TERT-BUTYL 3-AMINO-3-METHYLPYRROLIDINE-1-CARBOXYLATE, 95.0%, 500mg

1-(4-methylbenzo[d]thiazol-2-yl)azetidin-3-ol, 95.0%, 5g

5-AMINOTETRAHYDRO-2H-PYRAN-3-OL HCL, 95.0%, 5g

N-[(2S)-1,2,3,4-Tetrahydro-5-methoxy-2-naphthalenyl]propanamide, 98%, 250mg

1-[4-(3-methylphenoxy)phenyl]methanamine, 100mg

tert-Butyl (6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate, 97%, 1g

FMOC-(S)-2-Amino-3-hydroxy-3-methylbutanoic acid, 97.0%, 10g

GC capillary column ROTI®Cap-1701, 15 m, 0.53 mm, 1.00 µm, 1 Piece(s)

(E)-4,4,5,5-Tetramethyl-2-(2-methylstyryl)-1,3,2-dioxaborolane, 95+%, 100mg

2-Chloro-8-fluoroquinoline, 95.0%, 1g

4-Bromo-1H-pyrrole-2-carbaldehyde, 95.0%, 5g

3-Methyl-1-[5-(trifluoromethyl)pyridin-2-yl]piperazine, 2g

Ethyl 2-(4-formylphenyl)acetate, 95.0%, 100mg